Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    17329193 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  A Phase-II Study Of Raltitrexed/Oxaliplatin Plus Radiotherapy Versus Radiotherapy In Subjects With Inoperable Esophageal Cancer
Condition: Inoperable Esophageal Cancer Stage I-III
Interventions: Drug: Raltitrexed;   Drug: Oxaliplatin;   Radiation: Radiotherapy

Indicates status has not been verified in more than two years